secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001746473-23-000036
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics shareholders elect directors, approve say-on-pay, ratify auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- All three Class III director nominees (Coulie, Crowell, Bruhn) elected; Coulie received 48.3M for, 1.1M withhold.
- Non-binding say-on-pay proposal approved with 47.99M for, 1.38M against, 36k abstain.
- Ratification of Deloitte & Touche LLP as auditor for FY2023 passed with 54.81M for, 12.5k against.
- Broker non-votes totaled 5,432,103 shares on director election and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000174647323000036/0001746473-23-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000174647323000036/plrx-20230607.htm
  HTML page:      https://secwatch.observer/filing/0001746473-23-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer